Cargando…

A rare case of de novo large cell neuroendocrine carcinoma of the prostate with long-term survival after cystoprostatectomy and androgen deprivation

Detalles Bibliográficos
Autores principales:	Miyakawa, Jimpei, Suzuki, Motofumi, Endo, Kaori, Nose, Yorito, Sato, Toshikazu, Kishida, Yukiko, Tamura, Koichi, Morinaga, Shoujiroh, Kume, Haruki, Homma, Yukio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157454/ https://www.ncbi.nlm.nih.gov/pubmed/30263889 http://dx.doi.org/10.1016/j.eucr.2018.09.013

Ejemplares similares

Long-term results of radical prostatectomy with immediate adjuvant androgen deprivation therapy for pT3N0 prostate cancer
por: Sato, Yuzuri Tsurumaki, et al.
Publicado: (2014)

Ultra-early versus early salvage androgen deprivation therapy for post-prostatectomy biochemical recurrence in pT2-4N0M0 prostate cancer
por: Taguchi, Satoru, et al.
Publicado: (2014)

Silicate Urolithiasis during Long-Term Treatment with Zonisamide
por: Taguchi, Satoru, et al.
Publicado: (2013)

The prognostic value of PD‐L1 expression in upper tract urothelial carcinoma varies according to platelet count
por: Miyama, Yu, et al.
Publicado: (2018)

Th1/17 polarization and potential treatment by an anti-interferon-γ DNA aptamer in Hunner-type interstitial cystitis
por: Akiyama, Yoshiyuki, et al.
Publicado: (2023)

Robotic-Assisted Laparoscopic Cystoprostatectomy for Prostatic Carcinosarcoma
por: Young, Jennifer L., et al.
Publicado: (2007)

Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation
por: Lipianskaya, Julia, et al.
Publicado: (2014)

A pilot study of autologous tumor lysate-loaded dendritic cell vaccination combined with sunitinib for metastatic renal cell carcinoma
por: Matsushita, Hirokazu, et al.
Publicado: (2014)

Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
por: Chen, Xuanrong, et al.
Publicado: (2022)

Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
por: Chen, Xuanrong, et al.
Publicado: (2023)

Clinicopathologic features of incidental prostatic adenocarcinoma in radical cystoprostatectomy specimens
por: Aytac, Berna, et al.
Publicado: (2011)

Refeeding syndrome after radical cystoprostatectomy: A case report
por: Ouaz, Mouna, et al.
Publicado: (2021)

Arterioureteral Fistula in the Setting of Radical Cystoprostatectomy and Ileal Conduit Creation
por: Zaveri, Sahil, et al.
Publicado: (2022)

Development of Nephrotic Syndrome after Administration of Sorafenib in a Case of Metastatic Renal Cell Carcinoma
por: Okuno, Yumiko, et al.
Publicado: (2011)

A case of miliary tuberculosis following transurethral surgery and prostate biopsy after intravesical Bacillus Calmette–Guerin immunotherapy
por: Kurokawa, Yoshiaki, et al.
Publicado: (2021)

Long‐term outcomes of androgen deprivation therapy in prostate cancer among Japanese men over 80 years old
por: Blas, Leandro, et al.
Publicado: (2021)

Multiple primary malignant neoplasms of the glottis, renal pelvis, urinary bladder, oral floor, prostate, and esophagus in a Japanese male patient: a case report
por: Mukaiyama, Yoshihiro, et al.
Publicado: (2014)

Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: a randomized controlled phase II a trial
por: Fujimura, Tetsuya, et al.
Publicado: (2015)

Incidence and risk factors of inguinal hernia after robot-assisted radical prostatectomy
por: Yamada, Yuta, et al.
Publicado: (2017)

Cystoprostatectomy with Ileal Neobladder for Treatment of Severe Cystitis Glandularis in an Aids Patient
por: Coelho, Rafael Ferreira, et al.
Publicado: (2008)

A multicenter, retrospective observational study investigating baseline characteristics and clinical outcomes in patients with hormone-sensitive prostate cancer treated with primary androgen deprivation therapy
por: Taguchi, Satoru, et al.
Publicado: (2023)

Dermatomyositis associated with prostate adenocarcinoma with neuroendocrine differentiation
por: Minagawa, Hideyuki, et al.
Publicado: (2021)

Androgen deprivation therapy prevents bladder cancer recurrence
por: Izumi, Koji, et al.
Publicado: (2014)

Renal Cell Carcinoma with Intraluminal Spread of the Entire Upper Urinary Tract
por: Kakutani, Shigenori, et al.
Publicado: (2013)

Incidentally Found Prostate Cancer and Influence on Overall Survival after Radical Cystoprostatectomy
por: Sruogis, Algimantas, et al.
Publicado: (2012)

The role of cystoprostatectomy in management of locally advanced prostate cancer: a systematic review
por: Yuan, Peng, et al.
Publicado: (2020)

The ‘prostate-muscle index’: a simple pelvic cavity measurement predicting estimated blood loss and console time in robot-assisted radical prostatectomy
por: Kimura, Naoki, et al.
Publicado: (2022)

Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy
por: Stensland, Kristian D, et al.
Publicado: (2022)

The effects of transurethral resection and cystoprostatectomy on dissemination of epithelial cells in the circulation of patients with bladder cancer
por: Desgrandchamps, F, et al.
Publicado: (1999)

Undiagnosed prostatic malignancy at the time of radical cystoprostatectomy after prior prostatic radiation therapy
por: Sharma, Pranav, et al.
Publicado: (2016)

Locally Recurrent Leiomyoma of the Bladder Refractory to Visually Complete Transurethral Resection: An Indication for Cystoprostatectomy
por: Mitchell, Katharina, et al.
Publicado: (2019)

Adenoma-carcinoma Sequence in the Bladder After Augmentation Cystoplasty
por: Naito, Akihiro, et al.
Publicado: (2014)

Autologous tumor lysate-loaded dendritic cell vaccination combined with Sunitinib for metastatic renal cell carcinoma
por: Kakimi, Kazuhiro, et al.
Publicado: (2014)

The effect of continuous androgen deprivation treatment on prostate cancer patients as compared with intermittent androgen deprivation treatment
por: Ku, Ja Yoon, et al.
Publicado: (2015)

The association between the parameters of uroflowmetry and lower urinary tract symptoms in prostate cancer patients after robot-assisted radical prostatectomy
por: Takeshima, Yuta, et al.
Publicado: (2022)

Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers
por: Zhang, Yan, et al.
Publicado: (2018)

Androgen deprivation and cognition in prostate cancer
por: Salminen, E, et al.
Publicado: (2003)

Androgen Deprivation Therapy and Cardiovascular Risk
por: Mourmouris, Panagiotis, et al.
Publicado: (2012)

Metabolic effects of androgen deprivation therapy
por: Choi, See Min, et al.
Publicado: (2015)

Cardiovascular Toxicities of Androgen Deprivation Therapy
por: Challa, Azariyas A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l6380pd6hg3usksfpgelhjc3f4